Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - ISTA PHARMACEUTICALS INC | Financial_Report.xls |
| 10-K - FORM 10-K - ISTA PHARMACEUTICALS INC | d275317d10k.htm |
| EX-31.1 - SECTION 302 CEO CERTIFICATION - ISTA PHARMACEUTICALS INC | d275317dex311.htm |
| EX-32.1 - SECTION 906 CEO CERTIFICATION - ISTA PHARMACEUTICALS INC | d275317dex321.htm |
| EX-31.2 - SECTION 302 CFO CERTIFICATION - ISTA PHARMACEUTICALS INC | d275317dex312.htm |
| EX-10.12 - EXECUTIVE EMPLOYMENT AGREEMENT DATED NOVEMBER 30, 2011 - ISTA PHARMACEUTICALS INC | d275317dex1012.htm |
| EX-10.13 - FORM OF EXECUTIVE EMPLOYMENT AGREEMENT DATED DECEMBER 2, 2011 - ISTA PHARMACEUTICALS INC | d275317dex1013.htm |
| EX-10.13.1 - SCHEDULE OF PARTIES TO EXECUTIVE EMPLOYMENT AGREEMENT - ISTA PHARMACEUTICALS INC | d275317dex10131.htm |
| EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. - ISTA PHARMACEUTICALS INC | d275317dex231.htm |
Exhibit 32.2
Certification
I, Lauren P. Silvernail, Chief Financial Officer and Vice President, Corporate Development of ISTA Pharmaceuticals, Inc. (the “Company”), certify, pursuant to Rule 13(a)-14(b) or Rule 15(d)-14(b) of the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350, that:
(1) the Annual Report on Form 10-K of the Company for the fiscal year ended December 31, 2010 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 780(d)); and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: February 27, 2012
| /S/ LAUREN P. SILVERNAIL |
| Lauren P. Silvernail, Chief Financial Officer and Vice President, |